Articles & Issues
- Language
- English
- Conflict of Interest
- In relation to this article, we declare that there is no conflict of interest.
- Publication history
-
Received January 28, 2026
Revised February 23, 2026
Accepted February 25, 2026
Available online July 25, 2026
-
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/3.0) which permits
unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
All issues
Gold Nanocluster-Conjugated Magnetic Immunocomplexes for Quantitative Detection of C-Reactive Protein
https://doi.org/10.1007/s11814-026-00690-7
Abstract
In extinction-based immunosorbent assays, enzymes are commonly used as signal transducers; however, their intrinsic
instability has prompted the search for more stable alternatives, such as inorganic nanomaterials. In this study, we developed
a robust signal transduction strategy utilizing the localized surface plasmon resonance (LSPR) of gold nanoclusters
(AuNCs) to generate distinct and easily interpretable extinction signals, which were applied to C-reactive protein
(CRP) quantification. To implement this, AuNCs and anti-CRP antibodies were co-immobilized on magnetic nanoparticles
(MNPs), preparing “MagANC immunocomplexes” that can be rapidly purified via magnetic separation. By exploiting the
seed-mediated growth of AuNCs, these immunocomplexes generated CRP-dependent extinction signals, enabling sensitive
quantification. This approach effectively eliminates the need for unstable enzymes while leveraging the superparamagnetic
properties of MNPs to simplify the purification process. The assay demonstrated a wide dynamic range of 0.001–1 µg/
mL with two complementary readouts: maximum LSPR wavelength (0.03–1 µg/mL) and the absorbance at 600 nm
(0.001–0.03 µg/mL). The limit of detection (LOD) was 1.58 ng/mL. Furthermore, the method showed excellent reliability
in CRP-spiked serum, with a mean recovery of 100.47% and a coefficient of variation of 4.79%. Overall, the proposed
MagANC strategy offers a practical, enzyme-free alternative for clinical CRP diagnostics, delivering a wide dynamic range
and competitive sensitivity with a simplified workflow.

